Inaedis
Spin-out from Princeton University (founded 2022) developing a room-temperature aerosol dehydration platform to convert liquid biologics and vaccines into dry powders for storage, transport and alternative delivery routes. The company provides R&D and laboratory-scale manufacturing services, has peer-reviewed publications validating the approach, and has received multiple government and foundation awards to advance commercialization.
Industries
Nr. of Employees
small (1-50)
Products
Room-temperature aerosol dehydration platform
Platform process that forms ultra-fine aerosols from liquid bioformulations and dries them at room temperature to produce stable dry powders without added heat or freezing.
Room-temperature aerosol dehydration platform
Platform process that forms ultra-fine aerosols from liquid bioformulations and dries them at room temperature to produce stable dry powders without added heat or freezing.
Services
R&D services for thermal stabilization of biologics and vaccines
Research and development services to develop and validate room-temperature powderized formulations of biologic drugs and vaccines.
Laboratory-scale and pilot-scale manufacturing services for dry powder biologics
Production services for generating laboratory-scale batches of dry powder biologic doses and preparation for pilot-scale manufacturing.
Inhaled biological drug development
Formulation and aerosolization development for high-quality inhaled biologics and inhalable powder candidates.
R&D services for thermal stabilization of biologics and vaccines
Research and development services to develop and validate room-temperature powderized formulations of biologic drugs and vaccines.
Laboratory-scale and pilot-scale manufacturing services for dry powder biologics
Production services for generating laboratory-scale batches of dry powder biologic doses and preparation for pilot-scale manufacturing.
Inhaled biological drug development
Formulation and aerosolization development for high-quality inhaled biologics and inhalable powder candidates.
Expertise Areas
- Thermostable vaccine and biologic formulation
- Aerosol-based dehydration and liquid atomization
- Dry powder inhalation formulation
- Stability and potency analytical testing
Key Technologies
- Room-temperature aerosol dehydration
- Submicron liquid atomization
- Aerosol-assisted particle synthesis
- Dry powder inhalation formulation